Julia Mirian Paulino

Dr. Julia Mirian Paulino

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2025 in Future Pharmacology
Verified
Journal Article
Open access
PDF file
NSNatalia Nascimento Silveira
Natalia Nascimento Silveira
AHAndrada Eduardo Heber
Andrada Eduardo Heber
JPJulia Mirian Paulino
Julia Mirian Paulino
NBNaiara Cristina da Silva Boaretto
Naiara Cristina da Silva Boaretto
Eduardo Ferreira MolinaEduardo Ferreira Molina
Eduardo Ferreira Molina
RSRaquel Alves Dos Santos
Raquel Alves Dos Santos
Backgorund/Objectives: Advances in nanotechnology have enabled conventional compounds with low bioavailability to achieve their full therapeutic potential by ensuring targeted tissue delivery. In this context, polymeric nanogels have emerged as a promising option for drug delivery due to their high loading capacity and excellent in vivo stability. Objectives: Given the growing potential of nanogels in drug delivery, their cytotoxicity and genotoxicity must be evaluated to ensure safety in biotechnological applications. This study assessed the genotoxic safety of nanogels synthesized via the reaction of Jeffamine® T-5000 polyoxypropylene triamine (PPO) monomers (Huntsman Chemical, The Woodlands, TX, USA) and poly (ethylene glycol) diglycidyl ether (DPEG) in varying proportions: 1:1 (Nano11), 1:3 (Nano13), and 2:3 (Nano23) PPO/DPEG. Additionally, we determined which of the two components exhibited lower toxicity against the CHO-K1 cell line (Chinese hamster ovary). Methods: To achieve this, short- and long-term cytotoxicity experiments were conducted using the XTT colorimetric assay and clonogenic survival assay, alongside the micronucleus test and comet assay for genotoxicity analysis. Results: The cytotoxicity assays (XTT, clonogenic, and trypan blue) indicated that the nanogels did not exhibit cytotoxic effects at concentrations up to 100 μg/mL, while the genotoxicity assays revealed no evidence of DNA or chromosomal damage at these levels. Conclusions: These findings underscore the safety profile of Jeffamine® T-5000 as an effective carrier, demonstrating its compatibility with DPEG and positioning it as a highly promising and innovative solution for advanced drug delivery systems.

21 April 2023 in Future Pharmacology
Verified
Journal Article
Open access
PDF file
JVJulia G. Vargas
Julia G. Vargas
AHAndrada Eduardo Heber
Andrada Eduardo Heber
Bruno Andrade FicoBruno Andrade Fico
Bruno Andrade Fico
JPJulia Mirian Paulino
Julia Mirian Paulino
NSNatalia Nascimento Silveira
Natalia Nascimento Silveira
Eduardo Ferreira MolinaEduardo Ferreira Molina
Eduardo Ferreira Molina
To evaluate possible structural changes and thermal stability of the polyurea unloaded and loaded with diclofenac sodium, polyurea networks based on polyetheramine containing polypropylene oxide (PPO) or polyethylene oxide (PEO) and hexamethylene diisocyanate trimer-HDI were synthesized. The formation of the network was controlled by sol-gel reactions, and the obtained materials were then characterized by different techniques (FTIR, XRD, TGA). Moreover, the amount of diclofenac released could be modulated as a function of time, studying the water absorption or swelling capacity, the cytotoxicity of the material and the amount of drug released. A choice was therefore made on the hydrophilicity of PEO- or PPO-based polyetheramine (with similar molecular weight), and the release profile was hereafter correlated with the water absorption by the PEO/PPO polyurea matrix. Links could finally be established between the release of diclofenac and the polyurea matrices properties, such as the nature of polymer (PEO/PPO) and the hydrophilicity (water uptake). Our objective here is to identify challenges and opportunities for the development of innovative functional biomaterials for health applications.

11 September 2024 in Drug and Chemical Toxicology
Verified
Journal Article
Closed access
MGMirian O. Goulart
Mirian O. Goulart
JPJulia Mirian Paulino
Julia Mirian Paulino
NSNatalia Nascimento Silveira
Natalia Nascimento Silveira
ABAriane F. Bertonha
Ariane F. Bertonha
RBRoberto G. S. Berlinck
Roberto G. S. Berlinck
RSRaquel Alves Dos Santos
Raquel Alves Dos Santos
Peptaibols are fungal peptides that exhibit efficacy against pathogen microorganisms. Trichokonin VI (TK-VI) and trichokonin VIII (TK-VIII) are known peptaibols isolated from the endolichenic fungi Hypocrea sp. Previous investigations reported that trichokonin VI presents antiproliferative effects on tumor cells. This study is pioneering in elucidating the genotoxic effects of TK-VI and TK-VIII, contributing to the thorough assessment of their safety as potential therapeutic agents. The present investigation aimed to evaluate the genotoxicity of TK-VI and TK-VIII on CHO-K1 cells. Cytotoxicity was evaluated using the XTT assay and clonogenic survival assays, followed by evaluation of DNA damage using the comet assay and micronucleus test conducted in vitro. The XTT assay results indicated IC50 values of 10.30 µM and 9.89 µM for TK-VI and TK-VIII, respectively. The clonogenic survival assay indicated that concentrations of 10 µM or higher completely inhibited the cell colony formation. In the comet assay, both TK-VI and TK-VIII increased the DNA damage score and the frequency of comet nuclei in all tested concentrations. In the micronucleus assay, TK-VI and TK-VIII at 10 µM increased the frequency of MN in CHO-K1 cells. Both TK-VI and TK-VIII exhibited genotoxic effects. Our findings underscore the importance of considering the genotoxicological safety of peptaibols, particularly when assessing their potential for other biological activities.

7 October 2025 in Natural Product Research
Verified
Journal Article
Closed access
JPJulia Mirian Paulino
Julia Mirian Paulino
NGNatália dos Santos Gonçalves
Natália dos Santos Gonçalves
AHAndrada Eduardo Heber
Andrada Eduardo Heber
ARArthur Barcelos Ribeiro
Arthur Barcelos Ribeiro
Carlos H.I. RamosCarlos H.I. Ramos
Carlos H.I. Ramos
RSRaquel Alves Dos Santos
Raquel Alves Dos Santos
The present study investigated the cellular inhibitory effects of cis-trimethoxystilbene (cis-TMS) on the chemoresistant MDA-MB-231 breast cancer cell line and the role of p53 in mediating the cellular responses to this compound. Treatment with cis-TMS significantly inhibited the growth of MDA-MB-231 cells, reducing the cell viability by approximately 75% at 2.5 µM and increasing apoptosis rates to nearly 20%. Silencing p53 in MCF-10A and MCF-7 cell lines revealed that cis-TMS-induced apoptosis and cell cycle arrest were p53-dependent. The interaction studies suggest that cis-TMS does not alter the conformation of p53 at low concentrations but may influence its activity at higher doses. The results suggest that cis-TMS selectively targets cancer cells with functional p53, offering a potential targeted therapy approach. However, the reliance on p53 and the risk of genomic instability pose limitations, requiring further research to optimise the therapeutic strategies involving cis-TMS.